From clinical trials to the regulatory process and beyond, patient engagement should be a critical part of every drug’s development and its subsequent post-approval lifecycle.
Patient engagement combines a patient’s knowledge, skills, ability and willingness to manage their own care with communications designed to promote positive behaviours. Patients want to be engaged in their healthcare decision-making process, and those who are engaged in their care tend to be healthier.
This spotlight on patient engagement looks at patients’ journeys and experiences, and how pharma can better engage – and empower – them to improve health outcomes.
- Read: Spotlight on Patient engagement September 2019 PME in full
